Recent Finacing
Recent Raise
Ethris is a clinical-stage Munich biotech developing inhaled mRNA therapeutics using stabilized non-immunogenic mRNA and lipidoid LNPs for pulmonary/nebulized delivery, advancing ETH47 type III interferon and protein-replacement programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
